Adenocarcinoma of the uterine cervix: why is it different? (Q38261137)

1 September 2017

1 reference

title

Adenocarcinoma of the uterine cervix: why is it different? (English)

1 reference

1 September 2017

1 reference

cervical adenocarcinoma

1 reference

1

Keiichi Fujiwara

1 reference

1 September 2017

2

Bradley Monk

1 reference

1 September 2017

Mojgan Devouassoux-Shisheboran

series ordinal

3

1 reference

1 September 2017

1 December 2014

1 reference

1 September 2017

Current Oncology Reports

1 reference

1 September 2017

16

1 reference

1 September 2017

12

1 reference

1 September 2017

416

1 reference

https://scigraph.springernature.com/pub.10.1007/s11912-014-0416-y

1 September 2017

0 references

cites work

Adenocarcinoma: a unique cervical cancer

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0416-Y

Laparoscopic extraperitoneal para-aortic lymphadenectomy in locally advanced cervical cancer: a prospective correlation of surgical findings with positron emission tomography/computed tomography findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0416-Y

Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a Gynecologic Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0416-Y

Combination chemotherapy of docetaxel and carboplatin in advanced or recurrent cervix cancer. A pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0416-Y

Improved survival with bevacizumab in advanced cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0416-Y

Annual report of Gynecologic Oncology Committee, Japan Society of Obstetrics and Gynecology, 2013.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0416-Y

Cervical cancer: effect of glandular cell type on prognosis, treatment, and survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0416-Y

Prognostic factors in adenocarcinoma of the uterine cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0416-Y

Which clinical/pathologic factors matter in the era of chemoradiation as treatment for locally advanced cervical carcinoma? Analysis of two Gynecologic Oncology Group (GOG) trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0416-Y

Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0416-Y

Mortality trends for cervical squamous and adenocarcinoma in the United States. Relation to incidence and survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0416-Y

Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0416-Y

Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0416-Y

Ovarian metastasis in carcinoma of the uterine cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0416-Y

Adenocarcinoma of the uterine cervix. Prognosis and patterns of failure in 367 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0416-Y

The relationship between positive peritoneal cytology and the prognosis of patients with FIGO stage I/II uterine cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0416-Y

Prognosis and clinicopathological characteristics of Ib-IIb adenocarcinoma of the uterine cervix in patients who have had radical hysterectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0416-Y

Gastric morphology and immunophenotype predict poor outcome in mucinous adenocarcinoma of the uterine cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0416-Y

Gastrointestinal immunophenotype in adenocarcinomas of the uterine cervix and related glandular lesions: a possible link between lobular endocervical glandular hyperplasia/pyloric gland metaplasia and 'adenoma malignum'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0416-Y

LKB1 somatic mutations in sporadic tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0416-Y

Mesonephric adenocarcinomas of the uterine cervix: a study of 11 cases with immunohistochemical findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0416-Y

Molecular characterization of adenocarcinoma and squamous carcinoma of the uterine cervix using microarray analysis of gene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0416-Y

Oncogenic mutations in cervical cancer: genomic differences between adenocarcinomas and squamous cell carcinomas of the cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0416-Y

Prognostic significance of adenocarcinoma histology in women with cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0416-Y

Phase III randomised controlled trial of neoadjuvant chemotherapy plus radical surgery vs radical surgery alone for stages IB2, IIA2, and IIB cervical cancer: a Japan Clinical Oncology Group trial (JCOG 0102)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0416-Y

Efficacy of neoadjuvant chemotherapy in patients with FIGO stage IB1 to IIA cervical cancer: an international collaborative meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0416-Y

Endocrine tumors of the uterine cervix: incidence, demographics, and survival with comparison to squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0416-Y

Comparison of molecular changes in cervical intraepithelial neoplasia in HIV-positive and HIV-indeterminate subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0416-Y

Putative gene loci associated with carcinogenesis and metastasis of endocervical adenocarcinomas of uterus determined by conventional and array-based CGH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0416-Y

Identification of copy number gain and overexpressed genes on chromosome arm 20q by an integrative genomic approach in cervical cancer: potential role in progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0416-Y

Mutations of the TP53 gene in adenocarcinoma and squamous cell carcinoma of the cervix: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0416-Y

Endocervical glandular lesions exhibiting gastric differentiation: an emerging spectrum of benign, premalignant, and malignant lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0416-Y

The outcome of advanced or recurrent non-squamous carcinoma of the uterine cervix after platinum-based combination chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0416-Y

Phase II study of concurrent chemoradiotherapy with high-dose-rate intracavitary brachytherapy in patients with locally advanced uterine cervical cancer: efficacy and toxicity of a low cumulative radiation dose schedule

21 January 2018

1 reference

12 December 2020

Concurrent chemoradiotherapy with paclitaxel and cisplatin for adenocarcinoma of the cervix.

1 reference

12 December 2020

Intestinal-type cervical adenocarcinoma in situ and adenocarcinoma exhibit a partial enteric immunophenotype with consistent expression of CDX2

1 reference

12 December 2020

Papillary serous carcinoma of the uterine cervix: a clinicopathologic study of 17 cases

1 reference

12 December 2020

Chemoradiation and adjuvant chemotherapy in advanced cervical adenocarcinoma

1 reference

12 December 2020

Well-differentiated villoglandular adenocarcinoma of the uterine cervix: a clinicopathological study of 24 cases.

1 reference

12 December 2020

Early invasive adenocarcinoma of the uterine cervix: criteria for nonradical surgical treatment

1 reference

12 December 2020

Paclitaxel, an active agent in nonsquamous carcinomas of the uterine cervix: a Gynecologic Oncology Group Study

1 reference

12 December 2020

Adenoma malignum (minimal deviation adenocarcinoma) of the uterine cervix. A clinicopathological and immunohistochemical analysis of 26 cases

1 reference

12 December 2020

Long-Term Outcome and Prognostic Factors for Adenocarcinoma/Adenosquamous Carcinoma of Cervix After Definitive Radiotherapy

1 reference

12 December 2020

A comparison of adenocarcinoma and squamous cell carcinoma of the cervix

1 reference

12 December 2020

Laparoscopic extraperitoneal paraaortic lymphadenectomy in patients with locally advanced cervical cancer

1 reference

12 December 2020

Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group study

1 reference

12 December 2020

Adenocarcinoma as an independent risk factor for disease recurrence in patients with stage IB cervical carcinoma

1 reference

12 December 2020

A phase III randomized trial of postoperative pelvic irradiation in Stage IB cervical carcinoma with poor prognostic features: follow-up of a gynecologic oncology group study

1 reference

12 December 2020

Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer

1 reference

12 December 2020

Phase II study of combination chemotherapy with docetaxel and carboplatin for locally advanced or recurrent cervical cancer

1 reference

12 December 2020

Unusual endocervical adenocarcinomas: an immunohistochemical analysis with molecular detection of human papillomavirus

1 reference

12 December 2020

10.1007/S11912-014-0416-Y

Identifiers

DOI

1 reference

PubMed ID

25325935

Dimensions Publication ID

1 September 2017

0 references

1 reference

PubMed ID

25325935